Company ALT5 Sigma Corporation Börse Stuttgart
Equities
5AR1
US47089W1045
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 EUR | +1.98% | +16.76% | +306.85% |
07-10 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
07-10 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Antonios Isaac
CEO | Chief Executive Officer | 69 | 15-04-30 |
Virland Johnson
DFI | Director of Finance/CFO | 64 | 17-08-20 |
Amol Soin
CTO | Chief Tech/Sci/R&D Officer | - | 20-01-28 |
Anthony Giordano
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Antonios Isaac
CEO | Chief Executive Officer | 69 | 15-04-30 |
Richard Butler
BRD | Director/Board Member | 75 | 15-04-30 |
Nael Hajjar
BRD | Director/Board Member | 40 | 18-07-31 |
John Bitar
BRD | Director/Board Member | 62 | 20-01-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 100,000 | 0 | 0 | 99.07 % |
Stock B | 1 | 11,671,092 | 11,563,092 ( 99.07 %) | 0 | |
Stock C | 0 | 193,730 | 0 | 0 |
Company contact information
JanOne, Inc.
325 East Warm Springs Road Suite 102
89119-4238, Las Vegas
+702 997 5968
http://www.janone.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+25.13% | 47.96B | |
+2.16% | 42.45B | |
+44.19% | 41.47B | |
+27.46% | 31.6B | |
+21.53% | 28.63B | |
-6.35% | 28.03B | |
+52.24% | 14.56B | |
+47.30% | 14.14B | |
+4.08% | 12.58B |
- Stock Market
- Equities
- ALTS Stock
- 5AR1 Stock
- Company ALT5 Sigma Corporation